Fig. 2From: Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysisRisk of bias assessment using the Risk of Bias 2.0 tool. As the EMPUSLE trial results are not published yet, its risk of bias assessment was done based on its published design and the publicly available American Heart Association 2021 presentationBack to article page